Menopause and Heart Disease Risk: What the SWAN Study Reveals

Yes — heart disease risk rises significantly after menopause, and cardiovascular disease is the leading cause of death in women, claiming more lives than all cancers combined. Before menopause, women have relatively lower rates of heart disease than men of the same age. After menopause, that gap narrows sharply as women's risk accelerates.

For decades this was blamed simply on aging. But the SWAN study (Study of Women's Health Across the Nation), which followed thousands of women through the menopause transition, showed something more specific: cardiovascular risk factors worsen during the transition itself, over and above what age alone would predict. In 2020, the American Heart Association issued a scientific statement (El Khoudary et al., Circulation 2020) formally recognizing the menopause transition as a period of accelerating cardiovascular risk that deserves dedicated attention.

This reframing matters. It means the years around menopause are a critical window to assess and protect heart health — not a time to wait and see. Many women focus on hot flashes and sleep while the most life-threatening change happens quietly in the background.

Estrogen is cardioprotective, and losing it removes several layers of defense at once. Estrogen helps keep blood vessels flexible, supports healthy cholesterol levels, and has anti-inflammatory effects on the vascular system. As estrogen declines, several things shift in the wrong direction:

• •Cholesterol worsens. SWAN documented that LDL ("bad") cholesterol rises sharply around the final menstrual period, and particle patterns become more atherogenic (more likely to clog arteries).
• •Blood pressure climbs. Loss of estrogen's vessel-relaxing effect contributes to rising blood pressure; see our guide to [menopause and blood pressure](/blog/menopause-and-blood-pressure-why-it-rises-and-what-helps).
• •Arteries stiffen. Studies show increased arterial stiffness across the transition, a marker of cardiovascular risk.
• •Fat redistributes. Body fat shifts toward the abdomen, increasing visceral fat, which is metabolically active and inflammatory.

These changes compound. Rising LDL plus higher blood pressure plus more visceral fat plus stiffer arteries create a meaningfully higher-risk profile within just a few years. Understanding this helps explain why the transition, not just old age, is the pivotal period.

The SWAN study is one of the most important sources of evidence on midlife women's cardiovascular health because it tracked the same women over many years through the transition. Its key cardiovascular findings include:

• •Cholesterol spikes around the final period. SWAN showed LDL cholesterol and apolipoprotein B rise most steeply in the year around the final menstrual period — a transition-specific effect, not gradual aging.
• •Visceral fat and heart risk grow together. Increases in abdominal and around-the-heart fat during the transition were linked to greater cardiovascular risk.
• •Hot flashes may be a heart signal. SWAN and related research found that frequent or persistent vasomotor symptoms (hot flashes and night sweats) are associated with poorer vascular health and higher cardiovascular risk, suggesting hot flashes may be more than a comfort issue.
• •Timing matters. The clustering of these changes around the final menstrual period supports treating this window as a distinct risk period.

Together, these findings reshaped how cardiologists and gynecologists think about midlife women. Heart protection is not only about statins later — it starts with awareness during the transition. The same window is critical for bones; see [osteoporosis prevention in menopause](/blog/osteoporosis-prevention-in-menopause-what-actually-works).

Heart symptoms in women are often subtler and easier to dismiss than the classic crushing chest pain, which is one reason women's heart disease is underdiagnosed. While chest discomfort is still the most common symptom, women more frequently experience:

• •Unusual or extreme fatigue (sometimes days before an event)
• •Shortness of breath with little exertion
• •Pain in the jaw, neck, back, or arm rather than the chest
• •Nausea, indigestion, or lightheadedness
• •Cold sweats or a sense of impending doom

Because these overlap with menopause symptoms like fatigue, palpitations, and anxiety, they are easy to attribute to hormones — which can delay care. The rule of thumb: new, unexplained, or worsening symptoms, especially with exertion, deserve urgent evaluation. It is always better to be checked and reassured. If you experience heart palpitations, our guide on [menopause heart palpitations](/blog/menopause-heart-palpitations-why-your-heart-races) explains when they are benign and when to worry. When in doubt about sudden severe symptoms, call emergency services.

The most powerful message about menopausal heart risk is that most of it is modifiable. The transition is the ideal moment to build cardiovascular defenses. Evidence-based priorities:

• •Move regularly. Aim for 150 minutes a week of moderate aerobic activity plus strength training. Exercise lowers blood pressure, improves cholesterol, and reduces visceral fat; see [resistance training for menopause](/blog/resistance-training-for-menopause-why-lifting-matters).
• •Eat for your arteries. A Mediterranean-style, [anti-inflammatory diet](/blog/anti-inflammatory-diet-for-menopause-what-to-eat) rich in vegetables, fish, olive oil, legumes, and whole grains is strongly linked to lower heart risk.
• •Know your numbers. Get blood pressure, LDL and HDL cholesterol, triglycerides, and blood sugar checked. You cannot manage what you have not measured.
• •Manage blood pressure aggressively. Even modest reductions cut stroke and heart-attack risk.
• •Do not smoke, and keep alcohol moderate.
• •Discuss hormone therapy in context. Started near the onset of menopause in appropriate candidates, HRT may have neutral-to-favorable cardiovascular effects, but it is not prescribed to prevent heart disease. The [timing hypothesis](/blog/when-to-start-hrt-the-timing-hypothesis-explained) guide explains the nuance — decide with your provider based on your full risk profile.

The theme is consistency, not perfection. Small, sustained changes in the menopause window pay large cardiovascular dividends for decades.